The largest database of trusted experimental protocols

5 protocols using sc 17750

1

Establishment and Characterization of mCRPC PDX Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Informed consent was obtained to collect human mCRPC tissues and generate the patient-derived xenograft tumors as described previously (male CB17 SCID mice between 4–6 weeks of age; maximum tumor size: 1000 mm3; housing ambient temperature: 20–26 °C; ambient humidity: 30–70%)37 (link),38 (link). The study was approved by the University of Washington Human Subjects Division institutional review board (no. 2341). All animal studies were approved by University of Washington IACUC and performed according to NIH guidelines. Molecular characterization of AR+ mCRPC LuCaP PDXs 70CR, 78CR, 81CR, 96CR, 105CR, 136CR and 147CR was previously described37 (link),38 (link). LuCaP PDX 167CR was established from a liver metastasis of a male who died of abiraterone-, carboplatin- and docetaxel-resistant CRPC. LuCaP 167CR expresses AR (mouse monoclonal [F39.4.1] anti-AR; #MU256-UC, Biogenex; dilution 1:60), responds to castration and is negative for synaptophysin (mouse monoclonal [D-4] anti-synaptophysin; #sc-17750, Santa Cruz Biotechnology; dilution 1:200). PDX cellular morphology recapitulates the original liver metastasis (Supplementary Fig. 8a; characterization as previously described37 (link)).
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC was performed on paraffin-embedded tissue sections. After deparaffinization, rehydration, and antigen retrieval with citrate buffer (Invitrogen), slides were permeabilized with 0.5% triton X-100. Slides were then blocked using a ready-to-use IHC kit (BioVision) as described by the manufacturer. Slides were then incubated with primary antibodies: anti-CXCR7 (1:50; R&D, MAB42273), mouse IgG control (1:100; R&D, MAB002), anti-phospho-Aurora A (Thr288) (1:1000; CST, 3079), mouse anti-SYP (1:500; Santa Cruz, sc-17750), and anti-AR (1:200; Santa Cruz, SC-186) overnight at 4°C in a humidity chamber. Slides were then washed with 1 × TBS 3 times for 5 minutes each time. For secondary antibodies, slides were incubated with IBSC-1-step HRP-anti-mouse, rat, and rabbit polymer provided in the kit. Slides were washed again with TBS (3 times for 5 minutes each time), then incubated with 3,3′- Diaminobenzidine (DAB) substrate for 1–5 minutes at room temperature. Slides were then counterstained with hematoxylin for 15 seconds, washed with running tap water, dehydrated in ethanol, cleared with xylene, and mounted with Permount (Fisher Chemical). Slides were visualized and imaged with an Olympus BX41 microscope bound to with Olympus UTV 0.5XC3 camera.
+ Open protocol
+ Expand
3

Synaptophysin and PSD95 Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
An equal amount of total protein (25ug) from each sample was loaded into each lane. The NuPAGE Bis-Tris (10 well, 4–12%, 1.5 mm) gel electrophoresis system was used under reducing conditions (Life Technologies). The iBlot dry-blotting system (Life Technologies) was used to electrophoretically transfer gels to nitrocellulose membranes. Odyssey TBS blocking solution (Li-Cor) was used to prevent nonspecific protein binding (1 hr at RT). Primary antibodies, in Odyssey blocking solution containing 0.2% Tween20 (overnight at 4°C), were: Synaptophysin (SYP) (1:1,000; sc-17750; Santa Cruz) and PSD95 (1:1,000; 2507S; Cell Signaling). Anti-GAPDH (1:50,000; 8245; Abcam) was used as an internal loading control. Blots were washed 4 × 5 min with TBS+0.1% Tween20 and then probed with the appropriate fluorescent secondary antibody (1:20,000; Invitrogen) for 1 hr at RT. The Odyssey Infrared Imaging System (LI-COR Biosciences) was used to image membranes and Empiria Studio v1.3 software was used for quantification of bands. Each protein band was normalized to its respective loading control and then analyzed as percentage of control (n = 6/group).
+ Open protocol
+ Expand
4

Cerebellar Histological Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cerebellar specimens from each animal were xed in 10% buffered formalin solution for 24 hours, then dehydrated in graded alcohol and embedded in para n. Serial sections of 5 μm thickness were cut and the following techniques were applied:
Hematoxylin and eosin (H&E) stain: to illustrate the general histological features of the cerebellum (Gamble and M, 2008).
Immunohistochemical stains using streptavidin-biotin-peroxidase technique according to (Shalaby and Bahey, 2018) . The sections were incubated for 2 hours with the following: Diluted primary antibody against glial brillary acidic protein (GFAP); a mouse monoclonal antibody (SC-58766, Santa Cruz Biotechnology, INC).
Monoclonal antibody against synaptophysin (SC-17750, Santa Cruz Biotechnology, INC).
+ Open protocol
+ Expand
5

Cerebellar Histological Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cerebellar specimens from each animal were xed in 10% buffered formalin solution for 24 hours, then dehydrated in graded alcohol and embedded in para n. Serial sections of 5 μm thickness were cut and the following techniques were applied:
Hematoxylin and eosin (H&E) stain: to illustrate the general histological features of the cerebellum (Gamble and M, 2008).
Immunohistochemical stains using streptavidin-biotin-peroxidase technique according to (Shalaby and Bahey, 2018) . The sections were incubated for 2 hours with the following: Diluted primary antibody against glial brillary acidic protein (GFAP); a mouse monoclonal antibody (SC-58766, Santa Cruz Biotechnology, INC).
Monoclonal antibody against synaptophysin (SC-17750, Santa Cruz Biotechnology, INC).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!